$DORM
Dorman Products, Inc.

2020 Q3 Form 10-Q Financial Statement

#000156459020048533 Filed on October 29, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $300.6M $253.8M $254.2M
YoY Change 18.45% 2.36% 6.73%
Cost Of Revenue $192.8M $166.9M $167.0M
YoY Change 15.54% 9.1% 14.84%
Gross Profit $107.8M $86.92M $87.15M
YoY Change 24.02% -8.5% -5.99%
Gross Profit Margin 35.86% 34.25% 34.29%
Selling, General & Admin $63.00M $59.96M $59.80M
YoY Change 5.07% 16.97% 19.79%
% of Gross Profit 58.44% 68.98% 68.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.500M $6.900M $6.800M
YoY Change 8.7% 2.99% 3.03%
% of Gross Profit 6.96% 7.94% 7.8%
Operating Expenses $63.00M $59.96M $60.00M
YoY Change 5.07% 16.97% 20.19%
Operating Profit $44.80M $26.96M $27.22M
YoY Change 66.15% -38.35% -36.37%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $33.00K $0.00
YoY Change -100.0% -45.9% -100.0%
Pretax Income $44.76M $27.00M $27.30M
YoY Change 65.79% -38.36% -36.36%
Income Tax $10.50M $5.688M $5.800M
% Of Pretax Income 23.45% 21.07% 21.25%
Net Earnings $34.26M $21.31M $21.50M
YoY Change 60.78% -37.36% -37.39%
Net Earnings / Revenue 11.4% 8.4% 8.46%
Basic Earnings Per Share $1.06 $0.66 $0.66
Diluted Earnings Per Share $1.06 $0.65 $0.66
COMMON SHARES
Basic Shares Outstanding 32.28M 32.52M 32.59M
Diluted Shares Outstanding 32.37M 32.59M 32.68M

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $170.5M $54.20M $38.40M
YoY Change 214.58% 2.07% -48.66%
Cash & Equivalents $170.5M $54.17M $38.42M
Short-Term Investments
Other Short-Term Assets $11.80M $16.20M $17.50M
YoY Change -27.16% 107.69% 103.49%
Inventory $283.3M $282.1M $291.7M
Prepaid Expenses
Receivables $405.3M $372.4M $376.6M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $870.9M $724.9M $724.3M
YoY Change 20.14% 20.42% 23.9%
LONG-TERM ASSETS
Property, Plant & Equipment $130.1M $137.4M $102.3M
YoY Change -5.31% 41.95% 9.65%
Goodwill $91.15M $74.46M $72.60M
YoY Change 22.42% -7.0% 8.49%
Intangibles $21.97M $23.85M
YoY Change 6.12% 12.36%
Long-Term Investments
YoY Change
Other Assets $40.60M $52.07M $51.83M
YoY Change -22.02% 15.09% 16.81%
Total Long-Term Assets $287.9M $291.9M $291.9M
YoY Change -1.38% 18.13% 26.24%
TOTAL ASSETS
Total Short-Term Assets $870.9M $724.9M $724.3M
Total Long-Term Assets $287.9M $291.9M $291.9M
Total Assets $1.159B $1.017B $1.016B
YoY Change 13.96% 19.76% 24.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $112.8M $80.81M $102.3M
YoY Change 39.58% -17.48% 4.42%
Accrued Expenses $166.6M $14.60M $15.64M
YoY Change 1041.33% -19.19% -8.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $279.4M $195.6M $214.5M
YoY Change 42.88% 52.94% 75.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.629M $12.88M $14.02M
YoY Change -25.26% -6.91% 2.25%
Total Long-Term Liabilities $9.629M $12.88M $14.02M
YoY Change -25.26% -6.91% 2.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $279.4M $195.6M $214.5M
Total Long-Term Liabilities $9.629M $12.88M $14.02M
Total Liabilities $327.5M $208.4M $228.5M
YoY Change 57.12% 47.1% 67.68%
SHAREHOLDERS EQUITY
Retained Earnings $774.1M $719.7M $698.5M
YoY Change 7.56% 10.0% 11.35%
Common Stock $57.22M $52.88M $51.84M
YoY Change 8.2% 10.99% 11.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $831.4M $772.6M $750.3M
YoY Change
Total Liabilities & Shareholders Equity $1.159B $1.017B $1.016B
YoY Change 13.97% 19.76% 24.56%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income $34.26M $21.31M $21.50M
YoY Change 60.78% -37.36% -37.39%
Depreciation, Depletion And Amortization $7.500M $6.900M $6.800M
YoY Change 8.7% 2.99% 3.03%
Cash From Operating Activities -$73.70M $23.20M $20.10M
YoY Change -417.67% 18.37% -22.09%
INVESTING ACTIVITIES
Capital Expenditures -$5.000M -$7.400M -$8.500M
YoY Change -32.43% 10.45% 66.67%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$4.900M -$7.400M -$8.500M
YoY Change -33.78% -78.3% 49.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -110.5M -100.0K -13.90M
YoY Change 110400.0% -98.61% -32.52%
NET CHANGE
Cash From Operating Activities -73.70M 23.20M 20.10M
Cash From Investing Activities -4.900M -7.400M -8.500M
Cash From Financing Activities -110.5M -100.0K -13.90M
Net Change In Cash -189.1M 15.70M -2.300M
YoY Change -1304.46% -172.35% 360.0%
FREE CASH FLOW
Cash From Operating Activities -$73.70M $23.20M $20.10M
Capital Expenditures -$5.000M -$7.400M -$8.500M
Free Cash Flow -$68.70M $30.60M $28.60M
YoY Change -324.51% 16.35% -7.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
33000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2317000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
26996000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
90000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44756000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
89775000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
84016000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5688000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18856000
us-gaap Net Income Loss
NetIncomeLoss
70919000
us-gaap Net Income Loss
NetIncomeLoss
66213000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32656000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17803000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.06
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.02
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32281000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32522000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32317000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32371000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32594000
CY2020Q3 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
1202000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34433000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9629000
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4006000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
324000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
56893000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
774148000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
831365000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1158833000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y2M12D
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
750332000
dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
57000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10497000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34259000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
21308000
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
18320000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32304686
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32304686
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
807132000
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
175000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34259000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
831365000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
986000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
504000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-295000
us-gaap Net Income Loss
NetIncomeLoss
70919000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
831365000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
727623000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
868000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-837000
us-gaap Net Income Loss
NetIncomeLoss
66213000
us-gaap Profit Loss
ProfitLoss
66213000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
21011000
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
2498000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
197000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
33000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1154000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-302000
us-gaap Share Based Compensation
ShareBasedCompensation
4069000
us-gaap Share Based Compensation
ShareBasedCompensation
3033000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11685000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-28276000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3093000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12231000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1360000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10174000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1923000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1976000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
20334000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-28444000
dorm Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
24690000
dorm Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
-8312000
dorm Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
15773000
dorm Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
-1429000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
145719000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
59650000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14308000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12061000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24656000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26369000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24656000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
99000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
99000000
dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
112000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
17313000
dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
24339000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17201000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24282000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
102149000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10712000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
68353000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43458000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
170502000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54170000
us-gaap Interest Paid Net
InterestPaidNet
680000
us-gaap Interest Paid Net
InterestPaidNet
116000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19575000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
28454000
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
568300000
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
530700000
dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P365D
CY2020Q3 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
489500000
CY2019Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
437900000
CY2020Q3 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
1300000
CY2019Q3 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
4300000
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
10900000
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
13600000
CY2020Q3 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
131622000
CY2019Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
114308000
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
146967000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
161866000
CY2020Q3 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
4703000
CY2019Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
4639000
CY2020Q3 us-gaap Inventory Net
InventoryNet
283292000
CY2019Q4 us-gaap Inventory Net
InventoryNet
280813000
CY2019Q4 us-gaap Goodwill
Goodwill
74458000
CY2018Q4 us-gaap Goodwill
Goodwill
72606000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
16690000
CY2019 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
1852000
CY2020Q3 us-gaap Goodwill
Goodwill
91148000
CY2019Q4 us-gaap Goodwill
Goodwill
74458000
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34407000
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8353000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26054000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
27117000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5812000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21305000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2500000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000.0
CY2020Q3 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0141
CY2020Q3 dorm Number Of Outstanding Letters Of Credit
NumberOfOutstandingLettersOfCredit
2
CY2019 dorm Estimated Underpayments Of Duties Amount
EstimatedUnderpaymentsOfDutiesAmount
2800000
CY2020Q2 dorm Payment Of Underpaid Duties And Interest
PaymentOfUnderpaidDutiesAndInterest
2800000
dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P365D
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
791532000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
751762000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
300620000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
253796000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
791532000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
751762000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
177491
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
76.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
82905
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
63.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
25314
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
70.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
27703
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
77.41
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
207379
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
71.84
CY2020Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
300000
CY2019Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
200000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
800000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
500000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
181712
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
70.78
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
109352
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
63.25
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8764
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
65.24
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6630
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
56.52
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
275670
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
68.32
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4695637
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
99017
CY2020Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
65.99
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1917351
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
141000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
96000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34259000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
21308000
us-gaap Net Income Loss
NetIncomeLoss
70919000
us-gaap Net Income Loss
NetIncomeLoss
66213000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32281000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.03
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.06
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.02
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32522000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32317000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32656000
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
90000
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
72000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
77000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
82000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32371000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32594000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32394000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32738000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.06
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.19
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
15280
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1100000
dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
73.49
CY2019 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
22380
CY2019 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1900000
CY2019 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
87.26
us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2020-12-31
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2022-12-31
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1100000
CY2020Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1000000.0
CY2020Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
100000

Files In Submission

Name View Source Status
0001564590-20-048533-index-headers.html Edgar Link pending
0001564590-20-048533-index.html Edgar Link pending
0001564590-20-048533.txt Edgar Link pending
0001564590-20-048533-xbrl.zip Edgar Link pending
dorm-10q_20200926.htm Edgar Link pending
dorm-10q_20200926_htm.xml Edgar Link completed
dorm-20200926.xsd Edgar Link pending
dorm-20200926_cal.xml Edgar Link unprocessable
dorm-20200926_def.xml Edgar Link unprocessable
dorm-20200926_lab.xml Edgar Link unprocessable
dorm-20200926_pre.xml Edgar Link unprocessable
dorm-ex311_8.htm Edgar Link pending
dorm-ex312_6.htm Edgar Link pending
dorm-ex32_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gaxqvasufmem000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending